438 related articles for article (PubMed ID: 16404850)
1. Rapidly growing mycobacteria in King Chulalongkorn Memorial Hospital and review of the literature in Thailand.
Phowthongkum P; Prasanthai V; Udomsantisook N; Suankratay C
J Med Assoc Thai; 2005 Aug; 88(8):1153-62. PubMed ID: 16404850
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of rapidly growing Mycobacteria isolates in a general hospital: reports from the hospital microbiology laboratory].
Tazawa S; Marumo K; Nakamura Y; Narushima M; Higuchi D
Kekkaku; 2001 May; 76(5):419-26. PubMed ID: 11449697
[TBL] [Abstract][Full Text] [Related]
3. Nontuberculous mycobacterial infections in King Chulalongkorn Memorial Hospital.
Saritsiri S; Udomsantisook N; Suankratay C
J Med Assoc Thai; 2006 Dec; 89(12):2035-46. PubMed ID: 17214054
[TBL] [Abstract][Full Text] [Related]
4. [Susceptibility to antimicrobial agents of rapidly growing mycobacteria].
Ruiz-Aragón J; García-Agudo L; Flores S; Rodríguez MJ; Marín P; García-Martos P
Rev Esp Quimioter; 2007 Dec; 20(4):429-32. PubMed ID: 18563216
[TBL] [Abstract][Full Text] [Related]
5. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
Reddy AK; Garg P; Babu KH; Gopinathan U; Sharma S
Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
[TBL] [Abstract][Full Text] [Related]
6. Treatment of mycobacterial exit-site infections in patients on continuous ambulatory peritoneal dialysis.
Kleinpeter MA; Krane NK
Adv Perit Dial; 2001; 17():172-5. PubMed ID: 11510269
[TBL] [Abstract][Full Text] [Related]
7. Rapidly growing mycobacterial infections: spectrum of diseases, antimicrobial susceptibility, pathology and treatment outcomes.
Sungkanuparph S; Sathapatayavongs B; Pracharktam R
J Med Assoc Thai; 2003 Aug; 86(8):772-80. PubMed ID: 12948277
[TBL] [Abstract][Full Text] [Related]
8. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility.
Uslan DZ; Kowalski TJ; Wengenack NL; Virk A; Wilson JW
Arch Dermatol; 2006 Oct; 142(10):1287-92. PubMed ID: 17043183
[TBL] [Abstract][Full Text] [Related]
9. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.
Shen GH; Wu BD; Hu ST; Lin CF; Wu KM; Chen JH
Int J Antimicrob Agents; 2010 Apr; 35(4):400-4. PubMed ID: 20138481
[TBL] [Abstract][Full Text] [Related]
10. Nontuberculous mycobacterial skin infections: clinical and bacteriological studies.
Mahaisavariya P; Chaiprasert A; Khemngern S; Manonukul J; Gengviniij N; Ubol PN; Pinitugsorn S
J Med Assoc Thai; 2003 Jan; 86(1):52-60. PubMed ID: 12678139
[TBL] [Abstract][Full Text] [Related]
11. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Woods GL; Bergmann JS; Witebsky FG; Fahle GA; Wanger A; Boulet B; Plaunt M; Brown BA; Wallace RJ
J Clin Microbiol; 1999 Jun; 37(6):1676-82. PubMed ID: 10325306
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous infection with rapidly-growing mycobacterial infection following heart transplant: a case report and review of the literature.
Freudenberger RS; Simafranca SM
Transplant Proc; 2006 Jun; 38(5):1526-9. PubMed ID: 16797350
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Rapidly Growing Mycobacteria Bloodstream Infections.
Rodriguez-Coste MA; Chirca I; Steed LL; Salgado CD
Am J Med Sci; 2016 Mar; 351(3):253-8. PubMed ID: 26992253
[TBL] [Abstract][Full Text] [Related]
14. Delayed post-operative wound infections due to non-tuberculous Mycobacterium.
Kalita JB; Rahman H; Baruah KC
Indian J Med Res; 2005 Dec; 122(6):535-9. PubMed ID: 16518006
[TBL] [Abstract][Full Text] [Related]
15. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.
Yang SC; Hsueh PR; Lai HC; Teng LJ; Huang LM; Chen JM; Wang SK; Shie DC; Ho SW; Luh KT
Antimicrob Agents Chemother; 2003 Jun; 47(6):1958-62. PubMed ID: 12760874
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel.
Cavusoglu C; Gurpinar T; Ecemis T
New Microbiol; 2012 Jan; 35(1):73-6. PubMed ID: 22378556
[TBL] [Abstract][Full Text] [Related]
18. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Gui J; Wang F; Hong CY; Li JL; Liang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
[TBL] [Abstract][Full Text] [Related]
19. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR
J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068
[TBL] [Abstract][Full Text] [Related]
20. Non-tuberculous mycobacterial infections of the skin: a retrospective study of 29 cases.
Lee WJ; Kang SM; Sung H; Won CH; Chang SE; Lee MW; Kim MN; Choi JH; Moon KC
J Dermatol; 2010 Nov; 37(11):965-72. PubMed ID: 21039785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
